2020 | A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Hepatocellular Carcinoma Risk Steadily Persists Over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION |
2020 | Sarcopenia: An Emerging Risk Factor for Non-Alcoholic Fatty Liver Disease | HEPATOLOGY INTERNATIONAL |
2020 | An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate | JOURNAL OF VIRAL HEPATITIS |
2020 | Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2020 | Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
| CLINICAL AND MOLECULAR HEPATOLOGY |
2020 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2020 | Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study | MODERN RHEUMATOLOGY |
2020 | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
2020 | Genetically Engineered Mouse Models for Liver Cancer
| CANCERS |
2019 | Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2019 | Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
| SCIENTIFIC REPORTS |
2019 | Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis | DIGESTIVE DISEASES AND SCIENCES |
2019 | Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
| CLINICAL AND MOLECULAR HEPATOLOGY |
2019 | Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
2019 | Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
| CLINICAL AND MOLECULAR HEPATOLOGY |
2019 | External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy | LIVER INTERNATIONAL |
2019 | Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea
| ANNALS OF SURGICAL TREATMENT AND RESEARCH |
2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
2019 | A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea | Journal of Hepatology |
2019 | A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer
| Journal of Clinical Medicine |
2019 | Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease | Hepatology |
2019 | Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma | Journal of Vascular and Interventional Radiology |
2019 | Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
| Cancers |
2019 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals | CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY |
2019 | Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status
| GUT AND LIVER |
2019 | Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model
| GUT AND LIVER |
2019 | Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease | EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY |
2019 | Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
| BMC CANCER |
2019 | Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
| PLOS ONE |
2019 | Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
| JOURNAL OF CLINICAL MEDICINE |
2019 | Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation | EUROPEAN RADIOLOGY |
2019 | Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis
| CANCERS |
2019 | Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
| SCIENTIFIC REPORTS |
2019 | Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers | LIVER INTERNATIONAL |
2019 | Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | CEREBROVASCULAR DISEASES |
2018 | Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level
| CLINICAL AND MOLECULAR HEPATOLOGY |
2018 | Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2018 | Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib | LIVER INTERNATIONAL |
2018 | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2018 | Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B | LIVER INTERNATIONAL |
2018 | Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
| GUT AND LIVER |
2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2018 | Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance | JOURNAL OF MEDICAL VIROLOGY |
2018 | Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
| GUT AND LIVER |
2018 | Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2017 | New trends on obesity and NAFLD in Asia | JOURNAL OF HEPATOLOGY |
2017 | Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study
| ONCOTARGET |
2017 | Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease | DIGESTIVE DISEASES AND SCIENCES |